Clinical Trials Directory

Trials / Completed

CompletedNCT04432922

Perceptions, Representations and Experiences of Septic Isolation of Hospitalized Patients for COVID-19 Infection

Perceptions, Representations and Experiences of Septic Isolation of Hospitalized

Status
Completed
Phase
Study type
Observational
Enrollment
15 (actual)
Sponsor
Centre Hospitalier Intercommunal Creteil · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to analyze the perceptions, representations and experiences of septic isolation of patients hospitalized for COVID-19 infection. This analysis could lead to better understanding and communication between the medical profession and patients in septic isolation in hospital. It would also provide patient-specific responses to their expectations, as to their families.

Detailed description

SARS-Cov2 is a new virus responsible for the COVID-19 pandemic. For the first time, it was observed in Wuhan, China in December 2019. For this previously unknown contagious disease, which can cause severe respiratory infections, isolation precautions in hospitals and public places are one of the cornerstones for fighting this pandemic. Hospital isolation precautions have been present since the 19th century as a means to control the spread of infections. Septic isolation includes contact isolation, droplets and air. Isolation precautions must be prescribed by a physician. To our knowledge, there are few studies about the impact of septic isolation on hospitalized patients at both the psychological level and the relationship with doctors. This study could enable a better understanding and communication between the medical profession and patients in septic isolation during hospitalization. It could also provide patient-specific responses to their expectations.

Conditions

Interventions

TypeNameDescription
OTHERHospitalized Patients for COVID-19 InfectionFace to face semi-directed interviews about perceptions, representations and experiences of septic isolation, including nine opened-questions.

Timeline

Start date
2020-11-01
Primary completion
2020-11-15
Completion
2020-11-15
First posted
2020-06-16
Last updated
2023-06-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04432922. Inclusion in this directory is not an endorsement.